Document Type : Original Article
Author
1 Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2 School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract
INTRODUCTION: This study aimed to assess the impact of coronary artery bypass grafting (CABG) on outcomes in elderly patients compared to younger patients.
METHOD: An observational case-control study was conducted involving 535 patients, divided into two groups: older adults (≥75 years) and younger adults (<75 years). All patients underwent CABG following a similar protocol. The primary endpoints focused on early post-procedure outcomes, including in-hospital mortality and the duration of ICU or hospital stay. Patients were followed up for six months, and secondary study endpoints included long-term mortality, left ventricular ejection fraction, re-hospitalization rates, and repeated revascularization.
RESULTS: 535 patients who underwent CABG were enrolled in this study. The smoking habit was significantly higher among younger adults (38.2% vs. 12.5%, P=0.001). Hypertension was more prevalent among older adults than younger adults (75% vs. 60%, P=0.044). LDL cholesterol serum levels were higher among younger adult patients (94.9±32.5 vs. 80.9±32.9, P=0.028). In-hospital death was not significantly different between younger and older adults (2.8% vs. 5.0%, P=0.34). Mortality in the six-month follow-up was non-significantly higher in the elderly (2.1% vs. 8.1%, P=0.06).
A significant proportion of patients in both groups (46.9% in younger patients vs. 40% in older ones, P=0.40) received dual antiplatelet therapy (DAPT) prior to CABG due to a recent myocardial infarction and receipt of a new stent, but without increased major bleeding in both groups.
CONCLUSION: CABG should be considered a viable treatment option for elderly patients with acceptable operative risk in current clinical practice.
Keywords
2. Doshmangir L, Khabiri R, Gordeev VS. Policies to address the impact of an aging population in IRAN. Lancet 2023; 401: 1078. https://doi.org/10.1016/S0140-6736(23)00179-4
3. The World Bank. Population growth (annual %)-Iran, Islamic rep. 2022. https://data. worldbank.org/indicator/SP.POP.
4. Leeson GW. The Growth, Ageing and Urbanisation of our World. Population Ageing 2018; 11: 107-15. https://doi.org/10.1007/s12062-018-9225-7
5. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349(9064): 1498-504. https://doi.org/10.1016/S0140-6736(96)07492-2
6. World Health Organization. The top ten causes of death. WHO fact sheet. Geneva: WHO, 2007.
7. Driver JA, Djoussé L, Logroscino G, Gaziano JM, Kurth T. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ 2008; 337: a2467. https://doi.org/10.1136/bmj.a2467
8. Sipahi I, Akay MH, Dagdelen S. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era. JAMA Intern Med 2014; 174(2): 223-30. https://doi.org/10.1001/jamainternmed.2013.12844
9. Deb S, Wijeysundera HC, Ko DT, Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. JAMA 2013; 310(19): 2086-95. https://doi.org/10.1001/jama.2013.281718
10. Zacek P, Dominik J. Coronary artery bypass grafting in the elderly: pros and cons after three-year follow-up. Croat Med J 2002; 43(6): 633-8.
11. Raja SG. Myocardial revascularization for the elderly: current options, role of off-pump coronary artery bypass grafting and outcomes. Curr Cardiol Rev 2012; 8(1): 26-36. https://doi.org/10.2174/157340312801215809
12. Hirose H, Amano A, Yoshida S, Takahashi A, Nagano N, Kohmoto T. Coronary artery bypass grafting in the elderly. Chest 2000; 117(5): 1262-70. https://doi.org/10.1378/chest.117.5.1262
13. Fuse K, Makuuchi H. Early and late results of coronary artery bypass grafting in the elderly. Jpn Circ J 1988; 52(5): 460-5. https://doi.org/10.1253/jcj.52.460
14. Hirose H, Amano A, Takahashi A Coronary artery bypass grafting for octogenarians: experience in a private hospital and review of the literature. Ann Thorac Cardiovasc Surg 2001; 7(5): 282-91.
15. Shan L, Saxena A, McMahon R, Newcomb A. Coronary artery bypass graft surgery in the elderly. A review of postoperative quality of life. Circulation 2013; 128(21): 2333-43. https://doi.org/10.1161/CIRCULATIONAHA.112.000729
16. Lemaire A, Soto C, Salgueiro L. The impact of age on outcomes of coronary artery bypass grafting. Journal of Cardiothoracic Surgery 2020; 15(1): 158. https://doi.org/10.1186/s13019-020-01201-3
17. Aikawa P, Cintra AR, Leite CA, Marques RH, da Silva CT, Afonso Mdos S, Paulitsch Fda S, Oss EA. Impact of coronary artery bypass grafting in elderly patients. Rev Bras Cir Cardiovasc 2013; 28(1): 22-8.
18. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al., Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-47. https://doi.org/10.1161/CIRCULATIONAHA.110.009449
19. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1736-88. https://doi.org/10.1016/s0140-6736(18)32203-7
20. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014; 35(42): 2929. https://doi.org/10.1093/eurheartj/ehu299
21. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117(4): e25-146. https://doi.org/10.1161/CIRCULATIONAHA.107.187998
22. Madhavan MV, Gersh BJ, Alexander KP, Granger CB, Stone GW. Coronary Artery Disease in Patients ≥80 Years of Age. J Am Coll Cardiol 2018; 71(18): 2015-40. https://doi.org/10.1016/j.jacc.2017.12.068
23. Holmes DR, Jr, Kip KE, Kelsey SF. Cause of death analysis in the NHLBI PTCA Registry: results and considerations for evaluating long-term survival after coronary interventions. J Am Coll Cardiol 1997; 30: 881-7. https://doi.org/10.1016/S0735-1097(97)00249-0
24. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358(4): 331-41. https://doi.org/10.1056/NEJMoa071804
25. Serruys PW, Ong AT, van Herwerden LA. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005; 4694): 575-81. https://doi.org/10.1016/j.accreview.2005.11.072
26. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, et al., Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381(9867): 629-38. https://doi.org/10.1016/S0140-6736(13)60141-5
27. Huber CH, Goeber V, Berdat P, Carrel T, Eckstein F. Benefits of cardiac surgery in octogenarians-a postoperative quality of life assessment. Eur J Cardiothorac Surg 2007; 31: 1099-105. https://doi.org/10.1016/j.ejcts.2007.01.055
28. Wiedemann D, Bernhard D, Laufer G, Kocher A. The elderly patient and cardiac surgery: a mini-review. Gerontology 2010; 56: 241-9. https://doi.org/10.1159/000248761
29. Hannan EL, Zhong Y, Berger PB, Walford G, Curtis JP, Wu C, et al., Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age. Am J Cardiol 2014; 113(5): 803-8. https://doi.org/10.1016/j.amjcard.2013.11.035
30. Chivasso P, Benedetto U. Coronary surgery in elderly: it is never too late. J Thorac Dis 2016; 8(12): E1641-E1643. https://doi.org/10.21037/jtd.2016.12.34
31. Sadeghi R, Haji Aghajani M, Miri R, Kachoueian N, Jadbabaei AN, Mahjoob MP, et al., Dual antiplatelet therapy before coronary artery bypass grafting in patients with myocardial infarction: a prospective cohort study. BMC Surg 2021; 21(1): 449. https://doi.org/10.1186/s12893-021-01436-4
32. Sadeghi R, Babahajian A, Sarveazad A, Kachoueian N, Bahardoust M. Dual Antiplatelet Therapy before Coronary Artery Bypass Grafting; a Systematic Review and Meta-Analysis. Arch Acad Emerg Med 2020; 8(1): e61.
33. De Rosa S, Polimeni A, Sabatino J, Indolfi C. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis. BMC Cardiovasc Disord 2017; 17(1): 240. https://doi.org/10.1186/s12872-017-0664-5
34. Sabharwal S, Wilson H, Reilly P, Gupte CM. Heterogenety of the definition of elderly age in current orthopaedic research. Springer Plus 2015; 4: 516. https://doi.org/10.1186/s40064-015-1307-x
35. Ono M, Serruys PW, Hara H, Kawashima H, Gao C, Wang R, et al., 10-Year Follow-Up After Revascularization in Elderly Patients with Complex Coronary Artery Disease. J Am Coll Cardiol 2021; 77(22): 2761-2773. https://doi.org/10.1016/j.jacc.2021.04.016
36. Writing Committee Members; Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, et al., 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022; 79(2): e21-e9. https://doi.org/10.1016/j.jacc.2021.09.006
)